Global Antidiabetic Biguanides Market Professional Survey Report 2017

November 2017 | 115 pages | ID: G3020E55CF6EN
QYResearch

Abstracts

This report studies Antidiabetic Biguanides in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• Pfizer
• AstraZeneca
• GlaxoSmithKline
• Merck & Co
• Eli Lilly
• Sanofi
• Takeda Pharmaceuticals
• Novo Nordisk
• Servier Laboratories
• Boehringer Ingelheim
• Bristol-Myers Squibb

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Metformin IR
• Metformin SR

By Application, the market can be split into

• Hospitals
• Clinics
• Other

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Antidiabetic Biguanides Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF ANTIDIABETIC BIGUANIDES

1.1 Definition and Specifications of Antidiabetic Biguanides
  1.1.1 Definition of Antidiabetic Biguanides
  1.1.2 Specifications of Antidiabetic Biguanides
1.2 Classification of Antidiabetic Biguanides
  1.2.1 Metformin IR
  1.2.2 Metformin SR
1.3 Applications of Antidiabetic Biguanides
  1.3.1 Hospitals
  1.3.2 Clinics
  1.3.3 Other
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ANTIDIABETIC BIGUANIDES

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Antidiabetic Biguanides
2.3 Manufacturing Process Analysis of Antidiabetic Biguanides
2.4 Industry Chain Structure of Antidiabetic Biguanides

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ANTIDIABETIC BIGUANIDES

3.1 Capacity and Commercial Production Date of Global Antidiabetic Biguanides Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Antidiabetic Biguanides Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Antidiabetic Biguanides Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Antidiabetic Biguanides Major Manufacturers in 2016

4 GLOBAL ANTIDIABETIC BIGUANIDES OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Antidiabetic Biguanides Capacity and Growth Rate Analysis
  4.2.2 2016 Antidiabetic Biguanides Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Antidiabetic Biguanides Sales and Growth Rate Analysis
  4.3.2 2016 Antidiabetic Biguanides Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Antidiabetic Biguanides Sales Price
  4.4.2 2016 Antidiabetic Biguanides Sales Price Analysis (Company Segment)

5 ANTIDIABETIC BIGUANIDES REGIONAL MARKET ANALYSIS

5.1 North America Antidiabetic Biguanides Market Analysis
  5.1.1 North America Antidiabetic Biguanides Market Overview
  5.1.2 North America 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Antidiabetic Biguanides Sales Price Analysis
  5.1.4 North America 2016 Antidiabetic Biguanides Market Share Analysis
5.2 China Antidiabetic Biguanides Market Analysis
  5.2.1 China Antidiabetic Biguanides Market Overview
  5.2.2 China 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Antidiabetic Biguanides Sales Price Analysis
  5.2.4 China 2016 Antidiabetic Biguanides Market Share Analysis
5.3 Europe Antidiabetic Biguanides Market Analysis
  5.3.1 Europe Antidiabetic Biguanides Market Overview
  5.3.2 Europe 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Antidiabetic Biguanides Sales Price Analysis
  5.3.4 Europe 2016 Antidiabetic Biguanides Market Share Analysis
5.4 Southeast Asia Antidiabetic Biguanides Market Analysis
  5.4.1 Southeast Asia Antidiabetic Biguanides Market Overview
  5.4.2 Southeast Asia 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Antidiabetic Biguanides Sales Price Analysis
  5.4.4 Southeast Asia 2016 Antidiabetic Biguanides Market Share Analysis
5.5 Japan Antidiabetic Biguanides Market Analysis
  5.5.1 Japan Antidiabetic Biguanides Market Overview
  5.5.2 Japan 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Antidiabetic Biguanides Sales Price Analysis
  5.5.4 Japan 2016 Antidiabetic Biguanides Market Share Analysis
5.6 India Antidiabetic Biguanides Market Analysis
  5.6.1 India Antidiabetic Biguanides Market Overview
  5.6.2 India 2012-2017E Antidiabetic Biguanides Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Antidiabetic Biguanides Sales Price Analysis
  5.6.4 India 2016 Antidiabetic Biguanides Market Share Analysis

6 GLOBAL 2012-2017E ANTIDIABETIC BIGUANIDES SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Antidiabetic Biguanides Sales by Type
6.2 Different Types of Antidiabetic Biguanides Product Interview Price Analysis
6.3 Different Types of Antidiabetic Biguanides Product Driving Factors Analysis
  6.3.1 Metformin IR of Antidiabetic Biguanides Growth Driving Factor Analysis
  6.3.2 Metformin SR of Antidiabetic Biguanides Growth Driving Factor Analysis

7 GLOBAL 2012-2017E ANTIDIABETIC BIGUANIDES SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Antidiabetic Biguanides Consumption by Application
7.2 Different Application of Antidiabetic Biguanides Product Interview Price Analysis
7.3 Different Application of Antidiabetic Biguanides Product Driving Factors Analysis
  7.3.1 Hospitals of Antidiabetic Biguanides Growth Driving Factor Analysis
  7.3.2 Clinics of Antidiabetic Biguanides Growth Driving Factor Analysis
  7.3.3 Other of Antidiabetic Biguanides Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ANTIDIABETIC BIGUANIDES

8.1 Pfizer
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 Pfizer 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Pfizer 2016 Antidiabetic Biguanides Business Region Distribution Analysis
8.2 AstraZeneca
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 AstraZeneca 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 AstraZeneca 2016 Antidiabetic Biguanides Business Region Distribution Analysis
8.3 GlaxoSmithKline
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 GlaxoSmithKline 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 GlaxoSmithKline 2016 Antidiabetic Biguanides Business Region Distribution Analysis
8.4 Merck & Co
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Merck & Co 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Merck & Co 2016 Antidiabetic Biguanides Business Region Distribution Analysis
8.5 Eli Lilly
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Eli Lilly 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Eli Lilly 2016 Antidiabetic Biguanides Business Region Distribution Analysis
8.6 Sanofi
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Sanofi 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Sanofi 2016 Antidiabetic Biguanides Business Region Distribution Analysis
8.7 Takeda Pharmaceuticals
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Takeda Pharmaceuticals 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Takeda Pharmaceuticals 2016 Antidiabetic Biguanides Business Region Distribution Analysis
8.8 Novo Nordisk
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Novo Nordisk 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Novo Nordisk 2016 Antidiabetic Biguanides Business Region Distribution Analysis
8.9 Servier Laboratories
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Servier Laboratories 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Servier Laboratories 2016 Antidiabetic Biguanides Business Region Distribution Analysis
8.10 Boehringer Ingelheim
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Boehringer Ingelheim 2016 Antidiabetic Biguanides Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Boehringer Ingelheim 2016 Antidiabetic Biguanides Business Region Distribution Analysis
8.11 Bristol-Myers Squibb

9 DEVELOPMENT TREND OF ANALYSIS OF ANTIDIABETIC BIGUANIDES MARKET

9.1 Global Antidiabetic Biguanides Market Trend Analysis
  9.1.1 Global 2017-2022 Antidiabetic Biguanides Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Antidiabetic Biguanides Sales Price Forecast
9.2 Antidiabetic Biguanides Regional Market Trend
  9.2.1 North America 2017-2022 Antidiabetic Biguanides Consumption Forecast
  9.2.2 China 2017-2022 Antidiabetic Biguanides Consumption Forecast
  9.2.3 Europe 2017-2022 Antidiabetic Biguanides Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Antidiabetic Biguanides Consumption Forecast
  9.2.5 Japan 2017-2022 Antidiabetic Biguanides Consumption Forecast
  9.2.6 India 2017-2022 Antidiabetic Biguanides Consumption Forecast
9.3 Antidiabetic Biguanides Market Trend (Product Type)
9.4 Antidiabetic Biguanides Market Trend (Application)

10 ANTIDIABETIC BIGUANIDES MARKETING TYPE ANALYSIS

10.1 Antidiabetic Biguanides Regional Marketing Type Analysis
10.2 Antidiabetic Biguanides International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Antidiabetic Biguanides by Region
10.4 Antidiabetic Biguanides Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ANTIDIABETIC BIGUANIDES

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL ANTIDIABETIC BIGUANIDES MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antidiabetic Biguanides
Table Product Specifications of Antidiabetic Biguanides
Table Classification of Antidiabetic Biguanides
Figure Global Production Market Share of Antidiabetic Biguanides by Type in 2016
Figure Metformin IR Picture
Table Major Manufacturers of Metformin IR
Figure Metformin SR Picture
Table Major Manufacturers of Metformin SR
Table Applications of Antidiabetic Biguanides
Figure Global Consumption Volume Market Share of Antidiabetic Biguanides by Application in 2016
Figure Hospitals Examples
Table Major Consumers in Hospitals
Figure Clinics Examples
Table Major Consumers in Clinics
Figure Other Examples
Table Major Consumers in Other
Figure Market Share of Antidiabetic Biguanides by Regions
Figure North America Antidiabetic Biguanides Market Size (Million USD) (2012-2022)
Figure China Antidiabetic Biguanides Market Size (Million USD) (2012-2022)
Figure Europe Antidiabetic Biguanides Market Size (Million USD) (2012-2022)
Figure Southeast Asia Antidiabetic Biguanides Market Size (Million USD) (2012-2022)
Figure Japan Antidiabetic Biguanides Market Size (Million USD) (2012-2022)
Figure India Antidiabetic Biguanides Market Size (Million USD) (2012-2022)
Table Antidiabetic Biguanides Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Antidiabetic Biguanides in 2016
Figure Manufacturing Process Analysis of Antidiabetic Biguanides
Figure Industry Chain Structure of Antidiabetic Biguanides
Table Capacity and Commercial Production Date of Global Antidiabetic Biguanides Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Antidiabetic Biguanides Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Antidiabetic Biguanides Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Antidiabetic Biguanides Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Antidiabetic Biguanides 2012-2017
Figure Global 2012-2017E Antidiabetic Biguanides Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Antidiabetic Biguanides Market Size (Value) and Growth Rate
Table 2012-2017E Global Antidiabetic Biguanides Capacity and Growth Rate
Table 2016 Global Antidiabetic Biguanides Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Antidiabetic Biguanides Sales (K Pcs) and Growth Rate
Table 2016 Global Antidiabetic Biguanides Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Antidiabetic Biguanides Sales Price (USD/Pcs)
Table 2016 Global Antidiabetic Biguanides Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Biguanides 2012-2017E
Figure North America 2012-2017E Antidiabetic Biguanides Sales Price (USD/Pcs)
Figure North America 2016 Antidiabetic Biguanides Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Biguanides 2012-2017E
Figure China 2012-2017E Antidiabetic Biguanides Sales Price (USD/Pcs)
Figure China 2016 Antidiabetic Biguanides Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Biguanides 2012-2017E
Figure Europe 2012-2017E Antidiabetic Biguanides Sales Price (USD/Pcs)
Figure Europe 2016 Antidiabetic Biguanides Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Biguanides 2012-2017E
Figure Southeast Asia 2012-2017E Antidiabetic Biguanides Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Antidiabetic Biguanides Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Biguanides 2012-2017E
Figure Japan 2012-2017E Antidiabetic Biguanides Sales Price (USD/Pcs)
Figure Japan 2016 Antidiabetic Biguanides Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Antidiabetic Biguanides 2012-2017E
Figure India 2012-2017E Antidiabetic Biguanides Sales Price (USD/Pcs)
Figure India 2016 Antidiabetic Biguanides Sales Market Share
Table Global 2012-2017E Antidiabetic Biguanides Sales (K Pcs) by Type
Table Different Types Antidiabetic Biguanides Product Interview Price
Table Global 2012-2017E Antidiabetic Biguanides Sales (K Pcs) by Application
Table Different Application Antidiabetic Biguanides Product Interview Price
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer Antidiabetic Biguanides Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Pfizer Antidiabetic Biguanides Business Region Distribution
Table AstraZeneca Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Antidiabetic Biguanides Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AstraZeneca Antidiabetic Biguanides Business Region Distribution
Table GlaxoSmithKline Information List
Table Product A Overview
Table Product B Overview
Table 2015 GlaxoSmithKline Antidiabetic Biguanides Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GlaxoSmithKline Antidiabetic Biguanides Business Region Distribution
Table Merck & Co Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co Antidiabetic Biguanides Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck & Co Antidiabetic Biguanides Business Region Distribution
Table Eli Lilly Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eli Lilly Antidiabetic Biguanides Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Eli Lilly Antidiabetic Biguanides Business Region Distribution
Table Sanofi Information List
Table Product A Overview
Table Product B Overview
Table 2016 Sanofi Antidiabetic Biguanides Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Sanofi Antidiabetic Biguanides Business Region Distribution
Table Takeda Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 Takeda Pharmaceuticals Antidiabetic Biguanides Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Takeda Pharmaceuticals Antidiabetic Biguanides Business Region Distribution
Table Novo Nordisk Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novo Nordisk Antidiabetic Biguanides Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novo Nordisk Antidiabetic Biguanides Business Region Distribution
Table Servier Laboratories Information List
Table Product A Overview
Table Product B Overview
Table 2016 Servier Laboratories Antidiabetic Biguanides Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Servier Laboratories Antidiabetic Biguanides Business Region Distribution
Table Boehringer Ingelheim Information List
Table Product A Overview
Table Product B Overview
Table 2016 Boehringer Ingelheim Antidiabetic Biguanides Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Boehringer Ingelheim Antidiabetic Biguanides Business Region Distribution
Table Bristol-Myers Squibb Information List
Figure Global 2017-2022 Antidiabetic Biguanides Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Antidiabetic Biguanides Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Antidiabetic Biguanides Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Antidiabetic Biguanides Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Antidiabetic Biguanides Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Antidiabetic Biguanides Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Antidiabetic Biguanides Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Antidiabetic Biguanides Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Antidiabetic Biguanides Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Antidiabetic Biguanides by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Antidiabetic Biguanides by Application 2017-2022
Table Traders or Distributors with Contact Information of Antidiabetic Biguanides by Region